Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

InMed Pharmaceuticals Inc. (INM) > Segments

BayMedica

Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Jun-30-22Jun-30-21Jun-30-20Jun-30-19Jun-30-18
   10-K10-K10-K10-KS-1S-1/A
Revenues  4.11.1    
            Revenue growth  279.6%     
Gross profit  1.70.5    
            Gross margin  41.4%49.9%    
EBIT  -1.2-5.2    
            EBIT margin  -29.3%-476.3%    
   
Revenue Mix  75.2%100.0%    

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy